Table 5.
Variable | TASC A&B (n=259) | TASC C&D (n=84) | P* |
---|---|---|---|
Age, year | 64.80±9.93 | 65.35±8.90 | 0.656 |
Male, n % | 219 (84.6%) | 84 (100%) | <0.001 |
CAD, n % | 133 (51.4%) | 59 (70.2%) | 0.002 |
Smoking, n % | 120 (46.3%) | 45 (53.6%) | 0.249 |
HT, n % | 129 (49.8%) | 45 (53.6%) | 0.549 |
HL, n % | 80 (30.9%) | 34 (40.5%) | 0.105 |
LDL, mg/dL | 136.77±33.96 | 154.18±53.51 | 0.006 |
HDL, mg/dL | 38.35±6.62 | 35.89±7.12 | 0.004 |
DM, n % | 87 (33.6%) | 27 (32.1%) | 0.807 |
CRF, n % | 58 (22.4%) | 12 (14.3%) | 0.109 |
LVEF, % | 58.25±10.14 | 57.69±9.88 | 0.658 |
Glucose, mg/dL | 105 (31) | 105 (24.5) | 0.560 |
Creatinine, mg/dL | 0.99 (0.34) | 1.02 (0.26) | 0.131 |
GFR, ml/min/1.73m2 | 82.49±29.40 | 80.73±29.57 | 0.634 |
Neutrophil | 4.57±1.34 | 5.56±1.30 | <0.001 |
Lymphocyte | 1.64±0.52 | 1.44±0.56 | 0.003 |
N/L ratio | 2.61 (1.30) | 3.99 (2.70) | <0.001 |
Chi-square test, student’s t- test and Mann-Whitney U test. CAD - coronary artery disease; CRF - chronic renal failure (Glomerular filtration rate<60 ml/min/1.73 m2); DM - diabetes mellitus; GFR - estimated glomerular filtration rate; HDL - high density lipoprotein cholesterol; HL - hyperlipdemia; HT - hypertension; LDL - low density lipoprotein cholesterol; LVEF - left ventricle ejection fraction; N/L ratio - Neutrophil/Lymphocyte ratio; PAD - peripheral artery disease; TASC - Trans Atlantic Inter-Society Consensus II classification